The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 12,601–12,700 of 31,469
Ballestri, S., Meschiari, E., Baldelli, E., Musumeci, F. E., Romagnoli, D., Trenti, T., Zennaro, R. G., Lonardo, A., & Loria, P. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0149 · Cited by 27
Nørager, C. B., Jensen, M. B., Weimann, A., & Madsen, M. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02579.x · Cited by 27
Argiana, V., Kanellos, P. T., Makrilakis, K., Eleftheriadou, I., Tsitsinakis, G., Kokkinos, A. D., Perrea, D. N., & Tentolouris, N. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0795-8 · Cited by 27
Tang, S. C. W., Leung, J. C. K., Chan, L. Y. Y., Cheng, A. S., Lan, H. Y., & Lai, K. N. (2010) · American Journal of Nephrology · doi:10.1159/000316056 · Cited by 27
Saito, H., Kagaya, M., Suzuki, M., Yoshida, A., & Naito, M. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17301 · Cited by 28
Sociodemographic Differences in Fast Food Price Sensitivity
Meyer, K. A., Guilkey, D. K., Ng, S. W., Duffey, K. J., Popkin, B. M., Kiefe, C. I., Steffen, L. M., Shikany, J. M., & Gordon‐Larsen, P. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13922 · Cited by 27
Nonalcoholic Steatohepatitis Associated With Metabolic Syndrome
Jung, K. Y., Cho, S. Y., Kim, H. J., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000065 · Cited by 27
North, K. E., Graff, M., Franceschini, N., Reiner, A. P., Feitosa, M. F., Carr, J. J., Gordon‐Larsen, P., Wojczynski, M. K., & Borecki, I. B. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834a94fb · Cited by 27
Lee, Y., Shin, H., Vassy, J. L., Kim, J. T., Cho, S., Kang, S. M., Choi, S. H., Kim, K. W., Park, K. S., Jang, H. C., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.013 · Cited by 27
Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly Muscovites
Metelskaya, V. A., Shkolnikova, M. A., Shalnova, S. A., Андреев, Е. М., Деев, А. Д., Jdanov, D. A., Школьников, В. М., & Vaupel, J. W. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.09.005 · Cited by 27
Li, Z.-F., Guo, Z., Yang, S.-G., et al. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.07.168 · Cited by 27
D’Amore, S., Vacca, M., Graziano, G., D’Orazio, A., Cariello, M., Martelli, N., Tullio, G. D., Salvia, R., Grandaliano, G., Belfiore, A., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.006 · Cited by 27
Deng, H., Li, Y., Su, Z., et al. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1274-8 · Cited by 27
Clapp, J. F., & Lopez, B. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.0040 · Cited by 27
Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients
Anan, F., Masaki, T., Umeno, Y., Yonemochi, H., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.010 · Cited by 27
1-Hour plasma glucose in obese youth
Manco, M., del Giudice, E. M., Spreghini, M. R., Cappa, M., Perrone, L., Brufani, C., Rustico, C., Morino, G. S., & Caprio, S. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0384-3 · Cited by 27
Oliver, P., Caimari, A., Díaz‐Rúa, R., & Palou, A. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.92 · Cited by 26
Lasram, M. M., El-Golli, N., Jrad-Lamine, A., Douib, I. B., Bouzid, K., Annabi, A. B., Fazâa, S. E., Abdelmoula, J., & Gharbi, N. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.10.002 · Cited by 27
Gupta, S. K., Mi, D., Dubé, M. P., Saha, C., Johnson, R. M., Stein, J. H., Clauss, M. A., Mather, K. J., Desta, Z., & Liu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060852 · Cited by 27
Selfridge, J. E., Wilkins, H., Lezi, E., Carl, S. M., Koppel, S. J., Funk, E., Fields, T. A., Lu, J., Tan, E. P., Slawson, C. M., et al. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9570-z · Cited by 28
Tan, K. K., & Kim, K. H. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/845172 · Cited by 27
Effects of alternate-day fasting on high-fat diet-induced insulin resistance in rat skeletal muscle
Higashida, K., Fujimoto, E., Higuchi, M., & Terada, S. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.06.007 · Cited by 28
Molecular Analysis of the Adiponectin Gene in Severely Obese Patients from Southern Italy
Daniele, A., Cammarata, R., Pasanisi, F., Finelli, C., Salvatori, G., Calcagno, G., Bracale, R., Labruna, G., Nardelli, C., Buono, P., et al. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000172976 · Cited by 27
Straznicky, N. E., Grima, M. T., Sari, C. I., Karapanagiotidis, S., Wong, C. Y., Eikelis, N., Dell, K. L., Lee, G., Nestel, P. J., Dixon, J. B., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3277 · Cited by 27
Şengül, C., & Duman, D. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.224.257 · Cited by 27
Índice HOMA (homeostasis model assessment) na prática clínica: uma revisão
de Oliveira, E. P., de Souza, M. L. D., & de Lima, M. D. D. A. (2005) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442005000400004 · Cited by 33
Nakhjavani, M., Asgharani, F., Khalilzadeh, O., et al. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f3ce10 · Cited by 27
Kim, T. H., Kim, E. K., Lee, M.-S., Lee, H., Hwang, W. S., Choe, S. J., Kim, T., Han, S. J., Kim, H. J., Kim, D. J., et al. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.010 · Cited by 27
Association of metabolic syndrome with insulin-like growth factors among adults in the US
Saydah, S., Ballard-Barbash, R. R., & Potischman, N. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9351-x · Cited by 27
Banasik, K., Justesen, J. M., Hornbak, M., Krarup, N. T., Gjesing, A. P., Sandholt, C. H., Jensen, T. S., Grarup, N., Andersson, Å., Jørgensen, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016542 · Cited by 28
Insulinemia e índice HOMA en niños y adolescentes chilenos
Salesa Barja, Y., Arnaíz, P., Domínguez, A., Villarroel, L. A., Cassis, B., Castillo, O., Salomó, G., Farías, M., Manuela Goycoolea, M., Quiroga, T., et al. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011001100007 · Cited by 27
Aksnes, T. A., Seljeflot, I., Torjesen, P. A., Høieggen, A., Moan, A., & Kjeldsen, S. E. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.012 · Cited by 27
El-Abhar, H. S., & Schaalan, M. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037757 · Cited by 27
F2‐Isoprostanes and Adiposity in Older Adults
Kanaya, A. M., Wassel, C. L., Stoddard, P. J., Harris, T. B., Cummings, S. R., Kritchevsky, S. B., Goodpaster, B. H., Green, C., Satterfield, S., Gross, M. D., et al. (2010) · Obesity · doi:10.1038/oby.2010.243 · Cited by 27
Hara, T., MATSUMURA, Y., YAMAMOTO, M., KITADO, T., NAKAO, H., Nakao, H., Suzuki, T., Yoshikawa, T., & Fujimoto, S. (2006) · 体力科學 · doi:10.7600/jspfsm.55.385 · Cited by 28
Anan, F., Takayuki, M., Takahashi, N., Nakagawa, M., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2009) · Hypertension Research · doi:10.1038/hr.2009.8 · Cited by 27
Guardado‐Mendoza, R., Jiménez-Ceja, L. M., Majluf‐Cruz, A., Kamath, S., Fiorentino, T. V., Casiraghi, F., Velazquez, A. O. C., DeFronzo, R. A., Dick, E. J., Davalli, A. M., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.205 · Cited by 27
Prevalencia de hiperandrogenismo y síndrome de ovario poliquístico en transexuales de mujer a hombre
Becerra-Fernández, A., López, G. P., Román, M. M., Martin-Lazaro, J. F., Pérez, M. J. L., Araque, N. A., Rodríguez-Molina, J. M., Sertucha, M. C. B., & Vilas, M. V. A. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.01.010 · Cited by 27
Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.009 · Cited by 27
Mohamadin, A. M., Habib, F., & Al-Saggaf, A. A. (2010) · Annals of Saudi Medicine · doi:10.4103/0256-4947.65255 · Cited by 27
Cardona, F., Túnez, I., Tasset, I., Murri, M., & Tinahones, F. J. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.03.001 · Cited by 27
Cormier, H., Rudkowska, I., Thifault, É., Lemieux, S., Couture, P., & Vohl, M. (2013) · Genes · doi:10.3390/genes4030485 · Cited by 27
THERAPEUTIC APPROACH IN INSULIN RESISTANCE WITH ACANTHOSIS NIGRICANS
Tankova, T. I., Koev, D. J., Dakovska, L. N., & Кirilov, G. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11327.x · Cited by 28
Uysal, Y., Wolters, B., Knop, C., & Reinehr, T. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.09.007 · Cited by 27
Timmons, T., Shen, C., Aldrovandi, G. M., Rollie, A., Gupta, S. K., Stein, J. H., & Dubé, M. P. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0162 · Cited by 27
Boyne, M. S., Osmond, C., Fraser, R. A., Reid, M. E., Taylor‐Bryan, C., Soares‐Wynter, S., & Forrester, T. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001790 · Cited by 27
Vieira, C. S., Martins, W. P., Fernandes, J. B. F., Soares, G. M., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2012) · Contraception · doi:10.1016/j.contraception.2011.12.011 · Cited by 27
Korcarz, C. E., Stein, J. H., Peppard, P. E., Young, T. B., Barnet, J. H., & Nieto, F. J. (2014) · SLEEP · doi:10.5665/sleep.4086 · Cited by 28
Huang, G. T.-W., Tang, E., Aakil, A., Anderson, S. W., Jara, H. J., Davda, M. N., Stroh, H., Travison, T. G., Bhasin, S., & Basaria, S. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4160 · Cited by 27
Prevalence and risk factors of metabolic syndrome in school adolescents of northeast China
Li, P., Jiang, R., Li, L., et al. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0336 · Cited by 27
Tan, B. K., Sivakumar, K., Bari, M. F., Vatish, M., & Randeva, H. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065254 · Cited by 27
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Kalaitzakis, E., Kandaraki, E., Tsourdi, E. A., Delkos, D., Papadakis, E. P., & Panidis, D. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0144 · Cited by 27
Seow, K., Hwang, J., Wang, P.-Y., Ho, L. T., & Juan, C. (2011) · Human Reproduction · doi:10.1093/humrep/der267 · Cited by 27
Longo, K. A., Govek, E. K., Nolan, A. L., McDonagh, T., Charoenthongtrakul, S., Giuliana, D. J., Morgan, K., Hixon, J., Zhou, C., Kelder, B., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183764 · Cited by 27
Reinehr, T., Kleber, M., Toschke, A. M., Woelfle, J., & Roth, C. L. (2011) · International Journal of Pediatric Obesity · doi:10.3109/17477166.2010.544739 · Cited by 27
The influence of the colon on postprandial glucagon-like peptide 1 (7-36) amide concentration in man
Robertson, M. D., Livesey, G., Morgan, L., Hampton, S., & Mathers, J. C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610025 · Cited by 27
Kaji, M., Nomura, M., Tamura, Y., & Ito, S. (2007) · The Journal of Medical Investigation · doi:10.2152/jmi.54.168 · Cited by 27
Apolipoprotein B-to-A1 Ratio as a Predictor of Acute Ischemic Nonembolic Stroke in Elderly Subjects
Kostapanos, M. S., Christogiannis, L. G., Bika, E., Bairaktari, E. T., Goudevenos, J. A., Elisaf, M., & Milionis, H. J. (2010) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.09.010 · Cited by 27
Fetal and Infant Growth and Glucose Tolerance in the Hertfordshire Cohort Study
Phillips, D. I. W., Goulden, P., Syddall, H. E., Sayer, A. A., Dennison, E. M., Martin, H. J., Cooper, C. C., & the Hertfordshire Cohort Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s145 · Cited by 28
Tsukagawa, E., Adachi, H., Hirai, Y., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04496.x · Cited by 27
Vendramini, M. F., Pereira, A. C., Ferreira, S. R. G., Kasamatsu, T. S., & Moisés, R. S. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.01.007 · Cited by 27
Uehara, S. K., & Rosa, G. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.09.006 · Cited by 27
Liao, C., Gao, W., Cao, W., Lv, J., Yu, C., Wang, S., Zhou, B., Pang, Z., Cong, L., Wang, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140595 · Cited by 28
Korish, A. A., & Arafah, M. (2007) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.02.006 · Cited by 27
Threshold for Improvement in Insulin Sensitivity with Adolescent Weight Loss
Abrams, P., Katz, L. E. L., Moore, R. H., Xanthopoulos, M. S., Bishop‐Gilyard, C. T., Wadden, T. A., & Berkowitz, R. I. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.04.003 · Cited by 27
Trepanowski, J. F., Kabir, M. M., Alleman, R. J., & Bloomer, R. J. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-82 · Cited by 27
The Association of Retinol-Binding Protein 4 With Metabolic Syndrome and Obesity in Adolescents
Lin, C.-J., Chu, N., Hung, Y., Chang, J., He, C., Hsiao, F., & Hsieh, C. (2012) · Clinical Pediatrics · doi:10.1177/0009922812459948 · Cited by 27
Body trunk fat and insulin resistance in post-pubertal obese adolescents
dos Santos, L. C., Cintra, I. D. P., Fisberg, M., & Martini, L. A. (2008) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802008000200004 · Cited by 27
Diabetes is More Lethal in Mexicans and Mexican-Americans Compared to Non-Hispanic Whites
Hunt, K. J., Gonzalez, M. E., López, R. O., Haffner, S. M., D, M. P. S. M., & González‐Villalpando, C. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.07.003 · Cited by 27
Inoue, K., Sakano, N., Ogino, K., Sato, Y., Wang, D.-H., Kubo, M., Takahashi, H., Kanbara, S., & Miyatake, N. (2013) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.12-122 · Cited by 27
Crujeiras, A. B., Parra, D., Goyenechea, E., Abete, I., & Martínez, J. A. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0019-9 · Cited by 27
Hypoglycemic effect of Lupinus mutabilis in healthy volunteers and subjects with dysglycemia.
Fornasini, M., Castro, J., Villacrés, E., Narváez, L., Villamar, M. A. P., & Baldeon, M. E. (2012) · PubMed · doi:10.1590/s0212-16112012000200012 · Cited by 35
Kweon, S., Shin, M., Lee, Y. H., Choi, J., Nam, H., Park, K.-S., Kim, D.-H., & Jeong, S. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-112 · Cited by 27
Regulation of Diet-Induced Adipose Tissue and Systemic Inflammation by Salicylates and Pioglitazone
Kim, M., Yamamoto, Y., Kim, K.-J., Kamei, N., Shimada, T., Liu, L., Moore, K., Woo, J. R., Shoelson, S. E., & Lee, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082847 · Cited by 27
Goodarzi, M. O., Xu, N., Cui, J., et al. (2008) · Human Reproduction · doi:10.1093/humrep/den065 · Cited by 27
Rosário, P. W., Reis, J. S., Amim, R., Fagundes, T. A., Calsolari, M. R., da Silva, S. C., & Purisch, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1803 · Cited by 27
Pérez-Torres, I., Ibarra‐Ibarra, B. R., Soria‐Castro, E., et al. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-086 · Cited by 27
Houjeghani, S., Gargari, B. P., & Farzadi, L. (2012) · Europe PMC (PubMed Central) · Cited by 28
Alter, R., de Luis, D. A., Izaola, O., Sagrado, M. G., Conde, R., Gago, T. A., Pacheco, D., González, J. M., & Velasco, M. C. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31620-5 · Cited by 27
Eyck, A. V., Hoorenbeeck, K. V., Winter, B. Y. D., et al. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.11.014 · Cited by 27
Krishnaveni, G. V., Veena, S. R., Srinivasan, K., Osmond, C., & Fall, C. H. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143231 · Cited by 27
Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study
Mahmoudi, T., Majidzadeh‐A, K., Farahani, H., et al. (2015) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.13.12.793 · Cited by 27
Erşan, İ., Battal, F., Aylanç, H., Kara, S., Arıkan, S., Tekin, M., Gencer, B., & Tufan, H. A. (2016) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2015.10.006 · Cited by 29
Stryjecki, C., Peralta‐Romero, J., Alyass, A., Karam-Araujo, R., Suarez, F., Gómez-Zamudio, J. H., Burguete-García, A. I., Cruz, M., & Meyre, D. (2016) · Scientific Reports · doi:10.1038/srep24472 · Cited by 27
de Matos, M. A., Duarte, T. C., Ottone, V. D. O., Sampaio, P. F. D. M., Costa, K. B., de Oliveira, M. F. A., Moseley, P. L., Schneider, S. M., Coimbra, C. C., de Melo, G. E. B. A., et al. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3178 · Cited by 29
Maternal and Fetal Lipid and Adipokine Profiles and Their Association with Obesity
Solis‐Paredes, J. M., y Sosa, S. E., Estrada‐Gutiérrez, G., Nava-Salazar, S., Ortega-Castillo, V., Rodríguez‐Bosch, M., Bravo-Flores, E., Espejel-Núñez, A., Tolentino‐Dolores, M., Gaona-Estudillo, R., et al. (2016) · International Journal of Endocrinology · doi:10.1155/2016/7015626 · Cited by 27
Chung, S., Hyun, M. H., Lee, E., & Seo, H. S. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3548-0 · Cited by 26
Insulin resistance: The linchpin between prediabetes and cardiovascular disease
Salazar, M. R., Carbajal, H. A., Espeche, W. G., Aizpurúa, M., Sisnieguez, C. E. L., Sisnieguez, B. C. L., Stavile, R. N., March, C. E., & Reaven, G. M. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115610057 · Cited by 27
Chao, T., Chen, I., Li, Y., Lee, P., & Tseng, S. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003497 · Cited by 27
Pérez‐Martínez, P., Alcala-Diaz, J. F., Kabagambe, E. K., García‐Ríos, A., Tsai, M. Y., Delgado‐Lista, J., Kolovou, G. D., Straka, R. J., Gómez-Delgado, F., Hopkins, P. N., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.05.009 · Cited by 27
The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome
Chen, L., Chien, C.-Y., Hsieh, C.-W., Chang, L., Huang, M.-H., Huang, W.-Y., Kuo, S., Chien, C., Lin, C., & Chien, R. (2016) · Medicine · doi:10.1097/md.0000000000003616 · Cited by 27
Shah, N. A., Ruiz, H. H., Zafar, U., Post, K. D., Buettner, C., & Geer, E. B. (2016) · Clinical Endocrinology · doi:10.1111/cen.13230 · Cited by 26
Klisic, A. N., Kotur‐Stevuljević, J., Kavarić, N., Martinović, M., & Matic, M. G. (2016) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-016-0325-1 · Cited by 27
Karaköse, M., Çalışkan, M., Arslan, M. S., Demirci, T., Karaköse, S., & Çakal, E. (2016) · Endocrine · doi:10.1007/s12020-016-1175-3 · Cited by 28
Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome
Biçer, M., Güler, A., Kocabaş, G. Ü., İmamoğlu, Ç., Baloğlu, A., Bilgir, O., Yüksel, A., Bozkaya, G., & Çalan, M. (2016) · Endocrine Research · doi:10.1080/07435800.2016.1255896 · Cited by 27
Mani, P., Ren, H.-Y., Neeland, I. J., McGuire, D. K., Ayers, C. R., Khera, A., & Rohatgi, A. K. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.028 · Cited by 27
An extended fatty liver index to predict non-alcoholic fatty liver disease
Kantartzis, K., Rettig, I., Staiger, H., Machann, J., Schick, F., Scheja, L., Gastaldelli, A., Bugianesi, E., Peter, A., Schulze, M. B., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.11.006 · Cited by 27
Lee, H.-S., Lee, S.-J., Yu, H.-J., Lee, J.-H., & Cho, H. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.12.043 · Cited by 27
Contreras, J. M. D. L. M., Colado‐Velázquez, J. I., Gómez-Viquez, N. L., Mailloux‐Salinas, P., Pérez-Torres, I., Aranda‐Fraustro, A., Carvajal, K., & Bravo, G. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.33 · Cited by 27
Marcovecchio, M. L., Bagordo, M., Marisi, E., de Giorgis, T., Chiavaroli, V., Chiarelli, F., & Mohn, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0638-6 · Cited by 28
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
